Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics and Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
Chapter 2 Market Overview
- Market Definition
- Organoids and Spheroids Overview
- Organoids Versus Spheroids
- Future Directions in Organoids and Spheroids Market
- Porter's Five Forces Analysis
- Threat of New Entrants (Moderate)
- Bargaining Power of Suppliers (Moderate to High)
- Bargaining Power of Buyers (Moderate)
- Threat of Substitutes (Moderate)
- Level of Competitiveness (High)
- Macroeconomic Factors Analysis
- Demographic Trends and Disease Burden
- Government Funding and Research Investments
- Healthcare Expenditure and Economic Growth
- Regulatory and Ethical Evolution
- Impact of U.S.-Iran Conflict on the Organoids and Spheroids Market
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Increasing Adoption of 3D Cell Culture Models Over Conventional 2D Cell Cultures
- Shift Toward Human-Relevant Alternatives to Animal Testing in Preclinical Research
- Rising Adoption of Organoids and Spheroids in Oncology Drug Discovery
- Market Restraints
- High Costs of Advanced 3D Cell Culture Systems
- Lack of Standardized Protocols and Quality Control
- Reproducibility Challenges
- Market Opportunities
- Expansion of Personalized Medicine and Precision Oncology
- Growing Applications of Organoids in Regenerative Medicine and Tissue Engineering
- Emergence of Automated High-Throughput Organoid Platforms
Chapter 4 Regulatory Landscape
- Overview
- Regulations and Standards by Country or Region
Chapter 5 Emerging Technologies and Patent Analysis
- Overview
- Emerging Technologies
- Advances in 3D Spheroid Engineering Technologies
- Integration of CRISPR and Genome Editing with Organoid Models
- Emergence of 3D Bioprinting for Complex Organoid Assembly
- Patent Analysis
- By Year
- By Jurisdiction
Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Market Analysis by Product Type
- Key Takeaways
- Organoids
- Spheroids
- Market Analysis by Application
- Key Takeaways
- Drug Discovery and Personalized Medicine
- Developmental Biology
- Disease Pathology Studies
- Drug Toxicity and Efficacy Testing
- Regenerative Medicine
- Market Analysis by End User
- Key Takeaways
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations
- Hospitals and Diagnostic Centers
- Other End Users
- Geographic Breakdown
- Market Analysis by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
Chapter 7 Competitive Intelligence
- Key Takeaways
- Competitive Landscape
- Strategic Analysis
List of Tables
Summary Table: Global Market for Organoids and Spheroids, by Region, Through 2031
Table 1: Difference between Organoids and Spheroids
Table 2: Porter’s Five Forces: Rating Scale
Table 3: Estimated Cancer Incidence Cases, by Region, 2022-2045
Table 4: Estimated Cancer Incidence Cases in Males in the U.S., by Cancer Site, 2025
Table 5: Estimated Cancer Incidence Cases in Females in the U.S., by Cancer Site, 2025
Table 6: Regulatory Landscape Governing Organoids and Spheroids Solutions, by Country or Region
Table 7: Number of Patents, by Jurisdiction, 2024-2025
Table 8: Global Market for Organoids and Spheroids, by Product Type, Through 2031
Table 9: Global Market for Organoids, by Region, Through 2031
Table 10: Global Market for Spheroids, by Region, Through 2031
Table 11: Global Market for Organoids and Spheroids, by Application, Through 2031
Table 12: Global Market for Organoids and Spheroids for Drug Discovery and Personalized Medicine, by Region, Through 2031
Table 13: Global Market for Organoids and Spheroids for Developmental Biology, by Region, Through 2031
Table 14: Global Market for Organoids and Spheroids for Disease Pathology Studies, by Region, Through 2031
Table 15: Global Market for Organoids and Spheroids for Drug Toxicity and Efficacy Testing, by Region, Through 2031
Table 16: Global Market for Organoids and Spheroids for Regenerative Medicine, by Region, Through 2031
Table 17: Global Market for Organoids and Spheroids, by End User, Through 2031
Table 18: Global Market for Organoids and Spheroids for Pharmaceutical and Biotechnology Companies, by Region, Through 2031
Table 19: Global Market for Organoids and Spheroids for Academic and Research Institutes, by Region, Through 2031
Table 20: Global Market for Organoids and Spheroids for Contract Research Organizations, by Region, Through 2031
Table 21: Global Market for Organoids and Spheroids for Hospitals and Diagnostic Centers, by Region, Through 2031
Table 22: Global Market for Organoids and Spheroids for Other End Users, by Region, Through 2031
Table 23: Global Market for Organoids and Spheroids, by Region, Through 2031
Table 24: North American Market for Organoids and Spheroids, by Country, Through 2031
Table 25: North American Market for Organoids and Spheroids, by Product Type, Through 2031
Table 26: North American Market for Organoids and Spheroids, by Application, Through 2031
Table 27: North American Market for Organoids and Spheroids, by End User, Through 2031
Table 28: European Market for Organoids and Spheroids, by Country, Through 2031
Table 29: European Market for Organoids and Spheroids, by Product Type, Through 2031
Table 30: European Market for Organoids and Spheroids, by Application, Through 2031
Table 31: European Market for Organoids and Spheroids, by End User, Through 2031
Table 32: Asia-Pacific Market for Organoids and Spheroids, by Country, Through 2031
Table 33: Asia-Pacific Market for Organoids and Spheroids, by Product Type, Through 2031
Table 34: Asia-Pacific Market for Organoids and Spheroids, by Application, Through 2031
Table 35: Asia-Pacific Market for Organoids and Spheroids, by End User, Through 2031
Table 36: South American Market for Organoids and Spheroids, by Country, Through 2031
Table 37: South American Market for Organoids and Spheroids, by Product Type, Through 2031
Table 38: South American Market for Organoids and Spheroids, by Application, Through 2031
Table 39: South American Market for Organoids and Spheroids, by End User, Through 2031
Table 40: MEA Market for Organoids and Spheroids, by Subregion, Through 2031
Table 41: MEA Market for Organoids and Spheroids, by Product Type, Through 2031
Table 42: MEA Market for Organoids and Spheroids, by Application, Through 2031
Table 43: MEA Market for Organoids and Spheroids, by End User, Through 2031
Table 44: Leading Providers of Organoids and Spheroids, 2025
Table 45: Recent Developments in the Organoids and Spheroids Market, January 2024 to June 2026
Table 46: Abbreviations Used in This Report
Table 47: Bio-Techne: Company Snapshot
Table 48: Bio-Techne: Financial Performance, FY 2023 and 2024
Table 49: Bio-Techne: Product Portfolio
Table 50: Corning Inc.: Company Snapshot
Table 51: Corning Inc.: Financial Performance, FY 2024 and 2025
Table 52: Corning Inc.: Product Portfolio
Table 53: Corning Inc.: News/Key Developments, 2025
Table 54: Greiner Bio-One International GmbH: Company Snapshot
Table 55: Greiner Bio-One International GmbH: Product Portfolio
Table 56: InSphero: Company Snapshot
Table 57: InSphero: Product Portfolio
Table 58: InSphero: News/Key Developments, 2024-2026
Table 59: Lonza: Company Snapshot
Table 60: Lonza: Financial Performance, FY 2024 and 2025
Table 61: Lonza: Product Portfolio
Table 62: Merck KGaA: Company Snapshot
Table 63: Merck KGaA: Financial Performance, FY 2024 and 2025
Table 64: Merck KGaA: Product Portfolio
Table 65: Merck KGaA: News/Key Developments, 2025
Table 66: Molecular Devices LLC.: Company Snapshot
Table 67: Molecular Devices LLC.: Product Portfolio
Table 68: Revvity: Company Snapshot
Table 69: Revvity: Financial Performance, FY 2024 and 2025
Table 70: Revvity: Product Portfolio
Table 71: STEMCELL Technologies: Company Snapshot
Table 72: STEMCELL Technologies: Product Portfolio
Table 73: Thermo Fisher Scientific Inc.: Company Snapshot
Table 74: Thermo Fisher Scientific Inc.: Financial Performance, FY 2024 and 2025
Table 75: Thermo Fisher Scientific Inc.: Product Portfolio
Table 76: List of a Few Emerging Startups/Market Disruptors
List of Figures
Summary Figure: Global Market Shares for Organoids and Spheroids, by Region, 2025
Figure 1: Porter's Five Forces Analysis: Organoids and Spheroids Market
Figure 2: Market Dynamics of Organoids and Spheroids
Figure 3: Emerging Technologies in the Organoids and Spheroids Market
Figure 4: Total Number of Patents, by Year, 2024 and 2025
Figure 5: Global Market Shares for Organoids and Spheroids, by Product Type, 2025
Figure 6: Global Market Shares for Organoids, by Region, 2025
Figure 7: Global Market Shares for Organoids, by Type, 2025
Figure 8: Global Market Shares for Spheroids, by Region, 2025
Figure 9: Global Market Shares for Spheroids, by Type, 2025
Figure 10: Global Market Shares for Organoids and Spheroids, by Application, 2025
Figure 11: Global Market Shares for Organoids and Spheroids for Drug Discovery and Personalized Medicine, by Region, 2025
Figure 12: Global Market Shares for Organoids and Spheroids for Developmental Biology, by Region, 2025
Figure 13: Global Market Shares for Organoids and Spheroids for Disease Pathology Studies, by Region, 2025
Figure 14: Global Market Shares for Organoids and Spheroids for Drug Toxicity and Efficacy Testing, by Region, 2025
Figure 15: Global Market Shares for Organoids and Spheroids for Regenerative Medicine, by Region, 2025
Figure 16: Global Market Shares for Organoids and Spheroids, by End User, 2025
Figure 17: Global Market Shares for Organoids and Spheroids for Pharmaceutical and Biotechnology Companies, by Region, 2025
Figure 18: Global Market Shares for Organoids and Spheroids for Academic and Research Institutes, by Region, 2025
Figure 19: Global Market Shares for Organoids and Spheroids for Contract Research Organizations, by Region, 2025
Figure 20: Global Market Shares for Organoids and Spheroids for Hospitals and Diagnostic Centers, by Region, 2025
Figure 21: Global Market Shares for Organoids and Spheroids for Other End Users, by Region, 2025
Figure 22: Global Market Shares for Organoids and Spheroids, by Region, 2025
Figure 23: North American Market Shares for Organoids and Spheroids, by Country, 2025
Figure 24: European Market Shares for Organoids and Spheroids, by Country, 2025
Figure 25: Asia-Pacific Market Shares for Organoids and Spheroids, by Country, 2025
Figure 26: South American Market Shares for Organoids and Spheroids, by Country, 2025
Figure 27: MEA Market Shares for Organoids and Spheroids, by Subregion, 2025
Figure 28: Bio-Techne: Revenue Share, by Business Unit, FY 2024
Figure 29: Bio-Techne: Revenue Share, by Country/Region, FY 2024
Figure 30: Corning Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 31: Corning Inc.: Revenue Shares, by Country/Region, FY 2025
Figure 32: Lonza: Revenue Shares, by Business Unit, FY 2025
Figure 33: Lonza: Revenue Shares, by Country/Region, FY 2025
Figure 34: Merck KGaA: Revenue Share, by Business Unit, FY 2025
Figure 35: Merck KGaA: Revenue Share, by Country/Region, FY 2025
Figure 36: Revvity: Revenue Shares, by Business Unit, FY 2025
Figure 37: Revvity: Revenue Shares, by Country/Region, FY 2025
Figure 38: Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 39: Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2025
